BGB-11417-201

Active, not recruiting

Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma

Beigene Study ID info

BGB-11417-201

ClinicalTrials.gov ID info

EudraCT Number info

2022-500687-35-00

China Drug Trials ID info

CTR20221815

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents